METHODS AND SYSTEMS FOR IDENTIFYING OR TREATING CENTRAL NERVOUS SYSTEMS DISEASE

METHOD FOR PREDICTION OF MORTALITY, FUNCTIONAL OUTCOME AND RECOVERY AFTER STATUS EPILEPTICUS

IMMOBILIZED PROTEIN SYSTEM FOR RAPID AND ENHANCED MULTIPLEXED DIAGNOSTICS

USE OF THE EMM ANTIGEN AS A BIOMARKER OF INHERITED GPI DEFICIENCIES

COMPOSITIONS AND METHODS FOR TREATING EPILEPSY

BIOMARKERS AND METHODS FOR DETECTION OF SEIZURES AND EPILEPSY

BIOMARKER COMPOSITION FOR PREDICTING PROGNOSIS OF BRAIN DISEASES CAUSED BY MICROPLASTIC EXPOSURE AND METHOD FOR PREDICTING PROGNOSIS USING SAME

IMMOBILIZED PROTEIN SYSTEM FOR RAPID AND ENHANCED MULTIPLEXED DIAGNOSTICS

BIOMARKERS AND METHODS FOR DETECTION OF SEIZURES AND EPILEPSY

COMPOSITION FOR DIAGNOSIS OR TREATMENT OF A CONDITION ASSOCIATED WITH INCREASED ACTIVITY OF EIF4E COMPRISING AN EIF4E INHIBITOR

COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISEASES

Biomarkers and methods for detection of seizures and epilepsy

6-oxo-pipecolic acid quantitation by mass spectrometry

METHOD OF MITIGATION OF DEATH FROM EPILEPTIC SEIZURES

Methods of selecting subjects for treatment with metabolomic modulators

MICRORNA-134 BIOMARKER

Methods utilizing leukocyte RNA expression in prognosis evaluation of medical interventions for epilepsy

BIOMARKERS AND METHODS FOR EVALUATION AND TREATMENT OF EPILEPTIC VS NON-EPILEPTIC SEIZURES / NO SEIZURES / PSYCHOGENIC NON-EPILEPTIC SEIZURES

Detection of an autoantibody

Biomarkers and methods for detection of seizures and epilepsy

Biomarkers and methods for detection of seizures and epilepsy

Early Diagnosis and Prognosis of Pre-Eclampsia

BIOMARKERS AND METHODS FOR DETECTION OF SEIZURES AND EPILEPSY

NOVEL SLICE CULTURES AND METHODS FOR DIAGNOSING NEURONAL DEGENERATION DISEASES

Biomarkers for seizures

Diagnostic and therapeutic methods for EFMR (epilepsy and mental retardation limited to females)

Method for the in vitro identification of drug-resistant epilepsy

Biomarkers for seizures

MODEL SYSTEMS FOR SCREENING MODULATORS OF mTOR SIGNALING

Knockout mouse, method for screening substance for suppressing mesial temporal lobe epilepsy, and method for selecting technique for suppressing mesial temporal lobe epilepsy

Identification, diagnosis, and treatment of neuropathologies, neurotoxicities, tumors, and brain and spinal cord injuries using electrodes with microvoltammetry

NEURAL SPECIFIC S100-BETA FOR BIOMARKER ASSAYS AND DEVICES FOR DETECTION OF A NEUROLOGICAL CONDITION

Method for detecting GABAA receptor autoantibodies

Immobilized protein system for rapid and enhanced multiplexed diagnostics

Methods for detecting autoantibodies against a GABA(A) receptor alpha 1 subunit and/or beta 3 subunit in autoimmune seizure and/or encephalitis

Biomarkers for seizures

BIOMARKERS FOR SEIZURES

NEURAL SPECIFIC S100B FOR BIOMARKER ASSAYS AND DEVICES FOR DETECTION OF A NEUROLOGICAL CONDITION

BIO-NANO-CHIP FOR ANTICONVULSANT DRUG SALIVARY ASSAY

Brain somatic mutations associated to epilepsy and uses thereof

Pathological state detection using dynamically determined body index range values

Methods of determining efficacy of cyclodextrin therapy

Methods for diagnosing and treating an LGI1 related autoimmune disease

METHOD FOR ASSESSMENT OF POTENTIAL FOR DEVELOPMENT OF DRAVET SYNDROME AND USE THEREOF

Antibody that specifically binds to an epitope in the tureet region of a human Kir channel

COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF MITOCHONDRIAL DISEASES

Methods for diagnosing and treating encephalitis or epilepsy

IDENTIFICATION, DIAGNOSIS, AND TREATMENT OF NEUROPATHOLOGIES, NEUROTOXICITIES, TUMORS, AND BRAIN AND SPINAL CORD INJURIES USING ELECTRODES WITH MICROVOLTAMMETRY

Diagnostic and therapeutic methods for EFMR (epilepsy and mental retardation limited to females)

Therapy for hyperexcitability disorders

COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL

Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level

Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level

COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL

COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL

Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level

MEMORY AND LEARNING IMPAIRMENTS ASSOCIATED WITH DISRUPTION OF EPHRIN RECEPTOR A6 (EphA6) GENE

Methods for identifying GLP-1 secretagogues

COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL

Methods of Identifying Improved NMDA Receptor Antagonists

MEASUREMENT OF NEURAL ACTIVITY

COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL

Methods of Treatment, and Diagnosis of Epilepsy by Detecting Mutations in the SCN1A Gene

Development of sensitive FRET sensors and methods of using the same

Multinetwork nerve cell assay platform with parallel recording capability

METHOD AND COMPOSITIONS FOR TREATING AND PREVENTING SEIZURES BY MODULATING ACID-SENSING ION CHANNEL ACTIVITY

Biomarkers for Niemann-pick C disease and related disorders

METHOD FOR IDENTIFYING CRMP MODULATORS

Methods for diagnosis of encephalitis

Method for modulating insulin production

Method for diagnosing a pervasive developmental disorder

System for seizure suppression

Memory and learning impairments associated with disruption of Ephrin receptor A6 (EphA6) gene

Brain-Associated Inhibitor of Tissue-Type Plasminogen Activator

Neuroprotection with Beta-Lactam Compounds

Method for the Mapping of the Epileptogenic Focus in the Pre-Surgical Evaluation of Patients with Intractable Epilepsy

Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level

Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level

Diagnostic methods for determining susceptibility to convulsive conditions

Identification, diagnosis, and treatment of neuropathologies, neurotoxicities, tumors, and brain and spinal cord injuries using electrodes with microvoltammetry

DETECTING ELECTRICAL ACTIVITY AND ASSESSING AGENTS FOR THE ABILITY TO INFLUENCE ELECTRICAL ACTIVITY

Receptor

Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level

Mutation associated with epilepsy

CaMKII/calcium channel binding-related compositions and methods

Diagnostic methods for determining susceptibility to convulsive conditions

Immunosorbent blood tests for assessing paroxysmal cerebral discharges

Diagnostic and prognostic methods and compositions for seizure- and plasticity-related disorders